Page last updated: 2024-09-03

reboxetine and Obesity

reboxetine has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berezniuk, I; Biswas, R; Creson, TK; Fricker, AD; Fricker, LD; Rodriguiz, RM; Wetsel, WC; Wilkins, JJ1
Carson, RE; Ding, YS; Gallezot, JD; Henry, S; Labaree, D; Lee, DE; Li, CS; Nabulsi, N; Neumeister, A; Planeta, B; Potenza, MN; Sinha, R1
Bozkurt, H; Şahin, S1
Appolinário, JC; Kapczinski, F; Silveira, RO; Zanatto, V1

Trials

1 trial(s) available for reboxetine and Obesity

ArticleYear
An open trial of reboxetine in obese patients with binge eating disorder.
    Eating and weight disorders : EWD, 2005, Volume: 10, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Bulimia Nervosa; Female; Humans; Morpholines; Obesity; Reboxetine; Treatment Outcome

2005

Other Studies

3 other study(ies) available for reboxetine and Obesity

ArticleYear
Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:7

    Topics: Age Factors; Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Carboxypeptidase H; Depression; Diazepam; Exploratory Behavior; Hindlimb Suspension; Maze Learning; Mice; Mice, Transgenic; Morpholines; Motor Activity; Obesity; Point Mutation; Reboxetine; Swimming

2013
Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
    NeuroImage, 2014, Feb-01, Volume: 86

    Topics: Adult; Biological Availability; Carbon Radioisotopes; Female; Humans; Male; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Reboxetine; Thalamus; Tissue Distribution

2014
Weight Loss Associated with Reboxetine Use in Adolescents.
    Journal of child and adolescent psychopharmacology, 2016, Volume: 26, Issue:1

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Humans; Mental Disorders; Morpholines; Obesity; Reboxetine; Weight Loss

2016